The endocrinology of human chorionic gonadotropin secreting testicular tumors

new methods in diagnosis

J. S. Cochran, P. C. Walsh, J. C. Porter, T. C. Nicholson, J. D. Madden, P. C. Peters

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Serum from 59 men with testicular masses was examined for the presence of human chorionic gonadotropin-beta. Results indicate: 1) In patients with testicular tumor human chorionic gonadotropin-beta serves as a sensitive and specific marker of tumor activity with an incidence of 28%. 2) Because human chorionic gonadotropin-beta levels correlate with response to therapy this test will be useful in selecting men for adjunctive irradiation or chemotherapy. 3) Radioimmunoassay for human chorionic gonadotropin-beta is far more sensitive and specific than conventional methods for detecting human chorionic gonadotropin production. 4) After unilateral orchiectomy for carcinoma of the testis elevated serum luteinizing hormone levels are common and may be unrelated to the presence or activity of residual tumor. 5) Human chorionic gonadotropin-beta producing tumors were associated with increased estradiol and testosterone levels and significantly depressed serum follicle stimulating hormone levels in this series. 6) The prognostic implications of the presence of human chorionic gonadotropin beta are not yet fully understood. The importance of this study is the fact that men with testicular tumors have a high incidence of human chorionic gonadotropin-beta secretion and this fact provides the physician with a powerful new tool for examining the various aspects of tumor activity. It also shows the feasibility for prospective screening of patients with a wide variety of neoplasms of differing histologic types.

Original languageEnglish (US)
Pages (from-to)549-555
Number of pages7
JournalJournal of Urology
Volume114
Issue number4
StatePublished - 1975

Fingerprint

Endocrinology
Testicular Neoplasms
Chorionic Gonadotropin
Serum
Neoplasms
Orchiectomy
Incidence
Residual Neoplasm
Follicle Stimulating Hormone
Tumor Biomarkers
Luteinizing Hormone
Radioimmunoassay
Testosterone
Testis
Estradiol
Carcinoma
Physicians
Drug Therapy

ASJC Scopus subject areas

  • Urology

Cite this

Cochran, J. S., Walsh, P. C., Porter, J. C., Nicholson, T. C., Madden, J. D., & Peters, P. C. (1975). The endocrinology of human chorionic gonadotropin secreting testicular tumors: new methods in diagnosis. Journal of Urology, 114(4), 549-555.

The endocrinology of human chorionic gonadotropin secreting testicular tumors : new methods in diagnosis. / Cochran, J. S.; Walsh, P. C.; Porter, J. C.; Nicholson, T. C.; Madden, J. D.; Peters, P. C.

In: Journal of Urology, Vol. 114, No. 4, 1975, p. 549-555.

Research output: Contribution to journalArticle

Cochran, JS, Walsh, PC, Porter, JC, Nicholson, TC, Madden, JD & Peters, PC 1975, 'The endocrinology of human chorionic gonadotropin secreting testicular tumors: new methods in diagnosis', Journal of Urology, vol. 114, no. 4, pp. 549-555.
Cochran JS, Walsh PC, Porter JC, Nicholson TC, Madden JD, Peters PC. The endocrinology of human chorionic gonadotropin secreting testicular tumors: new methods in diagnosis. Journal of Urology. 1975;114(4):549-555.
Cochran, J. S. ; Walsh, P. C. ; Porter, J. C. ; Nicholson, T. C. ; Madden, J. D. ; Peters, P. C. / The endocrinology of human chorionic gonadotropin secreting testicular tumors : new methods in diagnosis. In: Journal of Urology. 1975 ; Vol. 114, No. 4. pp. 549-555.
@article{922a5ccdba17495495551111e15c5ad7,
title = "The endocrinology of human chorionic gonadotropin secreting testicular tumors: new methods in diagnosis",
abstract = "Serum from 59 men with testicular masses was examined for the presence of human chorionic gonadotropin-beta. Results indicate: 1) In patients with testicular tumor human chorionic gonadotropin-beta serves as a sensitive and specific marker of tumor activity with an incidence of 28{\%}. 2) Because human chorionic gonadotropin-beta levels correlate with response to therapy this test will be useful in selecting men for adjunctive irradiation or chemotherapy. 3) Radioimmunoassay for human chorionic gonadotropin-beta is far more sensitive and specific than conventional methods for detecting human chorionic gonadotropin production. 4) After unilateral orchiectomy for carcinoma of the testis elevated serum luteinizing hormone levels are common and may be unrelated to the presence or activity of residual tumor. 5) Human chorionic gonadotropin-beta producing tumors were associated with increased estradiol and testosterone levels and significantly depressed serum follicle stimulating hormone levels in this series. 6) The prognostic implications of the presence of human chorionic gonadotropin beta are not yet fully understood. The importance of this study is the fact that men with testicular tumors have a high incidence of human chorionic gonadotropin-beta secretion and this fact provides the physician with a powerful new tool for examining the various aspects of tumor activity. It also shows the feasibility for prospective screening of patients with a wide variety of neoplasms of differing histologic types.",
author = "Cochran, {J. S.} and Walsh, {P. C.} and Porter, {J. C.} and Nicholson, {T. C.} and Madden, {J. D.} and Peters, {P. C.}",
year = "1975",
language = "English (US)",
volume = "114",
pages = "549--555",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - The endocrinology of human chorionic gonadotropin secreting testicular tumors

T2 - new methods in diagnosis

AU - Cochran, J. S.

AU - Walsh, P. C.

AU - Porter, J. C.

AU - Nicholson, T. C.

AU - Madden, J. D.

AU - Peters, P. C.

PY - 1975

Y1 - 1975

N2 - Serum from 59 men with testicular masses was examined for the presence of human chorionic gonadotropin-beta. Results indicate: 1) In patients with testicular tumor human chorionic gonadotropin-beta serves as a sensitive and specific marker of tumor activity with an incidence of 28%. 2) Because human chorionic gonadotropin-beta levels correlate with response to therapy this test will be useful in selecting men for adjunctive irradiation or chemotherapy. 3) Radioimmunoassay for human chorionic gonadotropin-beta is far more sensitive and specific than conventional methods for detecting human chorionic gonadotropin production. 4) After unilateral orchiectomy for carcinoma of the testis elevated serum luteinizing hormone levels are common and may be unrelated to the presence or activity of residual tumor. 5) Human chorionic gonadotropin-beta producing tumors were associated with increased estradiol and testosterone levels and significantly depressed serum follicle stimulating hormone levels in this series. 6) The prognostic implications of the presence of human chorionic gonadotropin beta are not yet fully understood. The importance of this study is the fact that men with testicular tumors have a high incidence of human chorionic gonadotropin-beta secretion and this fact provides the physician with a powerful new tool for examining the various aspects of tumor activity. It also shows the feasibility for prospective screening of patients with a wide variety of neoplasms of differing histologic types.

AB - Serum from 59 men with testicular masses was examined for the presence of human chorionic gonadotropin-beta. Results indicate: 1) In patients with testicular tumor human chorionic gonadotropin-beta serves as a sensitive and specific marker of tumor activity with an incidence of 28%. 2) Because human chorionic gonadotropin-beta levels correlate with response to therapy this test will be useful in selecting men for adjunctive irradiation or chemotherapy. 3) Radioimmunoassay for human chorionic gonadotropin-beta is far more sensitive and specific than conventional methods for detecting human chorionic gonadotropin production. 4) After unilateral orchiectomy for carcinoma of the testis elevated serum luteinizing hormone levels are common and may be unrelated to the presence or activity of residual tumor. 5) Human chorionic gonadotropin-beta producing tumors were associated with increased estradiol and testosterone levels and significantly depressed serum follicle stimulating hormone levels in this series. 6) The prognostic implications of the presence of human chorionic gonadotropin beta are not yet fully understood. The importance of this study is the fact that men with testicular tumors have a high incidence of human chorionic gonadotropin-beta secretion and this fact provides the physician with a powerful new tool for examining the various aspects of tumor activity. It also shows the feasibility for prospective screening of patients with a wide variety of neoplasms of differing histologic types.

UR - http://www.scopus.com/inward/record.url?scp=0016700755&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016700755&partnerID=8YFLogxK

M3 - Article

VL - 114

SP - 549

EP - 555

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 4

ER -